Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Department of Laboratory Medicine, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
J Glob Antimicrob Resist. 2023 Jun;33:155-163. doi: 10.1016/j.jgar.2023.01.005. Epub 2023 Jan 29.
Linezolid-resistant Staphylococcus capitis (LRSC) has become a new challenge for clinical anti-infective therapy. The present study aimed to investigate the trends of LRSC prevalence in a tertiary hospital of China 2017-2020. The resistance mechanisms, virulence genes, biofilm formation, and mass spectrometric characteristics of LRSC isolates were also analysed.
This study retrospectively analysed the antibiotic resistance trends of coagulase negative staphylococci (CoNS) isolated from clinical samples collected between 2017-2020. Antimicrobial resistance profiles were tested by micro-broth dilution and the E-test method. Antimicrobial resistance genes and virulence genes were detected by polymerase chain reaction, and dru-typing sequences were obtained by Sanger sequencing. Crystal violet staining in 96-well plates was used to detect biofilm formation ability. Mass spectrometric characterization of LRSC was analysed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) coupled with ClinProTools.
The linezolid resistance rate in 3575 CoNS clinical strains was 1.6%, wherein the great majority of was LRSC (91.1%, n = 51/56), with a resistant rate of 15.5% (n = 51/328) in all S. capitis isolates. In this study, 48 out of the 51 LRSC strains and 54 of 277 linezolid-susceptible S. capitis (LSSC) strains were enrolled. G2576T, C2104T, T2130A, C2163T, and T2319C mutations in the 23S rRNA V region and acquisition of cfr were the main linezolid resistant mechanisms in LRSC. The biofilm-forming ability of LRSC was more potent than LSSC, with a higher detection rate of bap (P < 0.05). Eleven mass spectrometric peaks of interest were identified by using MALDI-TOF MS and ClinProTools, which were differently distributed between LRSC and LSSC strains, with the area under the receiver operating characteristic curve of more than 0.8, especially for 5465.37 m/z.
Linezolid resistance was mediated by mutations in the 23S rRNA V region and presence of the cfr gene in LRSC strains. LRSC strains have stronger biofilm-forming ability than LSSC strains, which maybe associated with the adhesion-related gene of bap. Further, linezolid-resistant and linezolid-susceptible S. capitis could be rapidly identified with mass spectrometric characterization. To the best of our knowledge, this study is the first to document the biofilm formation ability of LRSC and the potential usefulness of MALDI-TOF MS for the discrimination of LRSC and LSSC.
耐利奈唑胺表皮葡萄球菌(LRSC)已成为临床抗感染治疗的新挑战。本研究旨在调查 2017-2020 年中国一家三级医院 LRSC 流行趋势。还分析了 LRSC 分离株的耐药机制、毒力基因、生物膜形成和质谱特征。
本研究回顾性分析了 2017-2020 年间临床分离的凝固酶阴性葡萄球菌(CoNS)的抗生素耐药趋势。采用微量肉汤稀释法和 E 试验法检测抗菌药物耐药谱。采用聚合酶链反应检测抗菌药物耐药基因和毒力基因,用 Sanger 测序获得 dru 型序列。用结晶紫染色法在 96 孔板中检测生物膜形成能力。采用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)联合 ClinProTools 分析 LRSC 的质谱特征。
3575 株 CoNS 临床分离株中利奈唑胺耐药率为 1.6%,其中绝大多数为 LRSC(91.1%,n=51/56),所有表皮葡萄球菌分离株中利奈唑胺耐药率为 15.5%(n=51/328)。本研究中,51 株 LRSC 株和 277 株利奈唑胺敏感表皮葡萄球菌(LSSC)株中的 48 株和 54 株被纳入。23S rRNA V 区 G2576T、C2104T、T2130A、C2163T 和 T2319C 突变以及 cfr 的获得是 LRSC 中利奈唑胺耐药的主要机制。LRSC 的生物膜形成能力强于 LSSC,bap 的检出率更高(P<0.05)。采用 MALDI-TOF MS 和 ClinProTools 鉴定到 11 个感兴趣的质谱峰,LRSC 和 LSSC 株之间的分布不同,ROC 曲线下面积大于 0.8,尤其是 5465.37 m/z。
LRSC 菌株中利奈唑胺耐药是由 23S rRNA V 区突变和 cfr 基因的存在介导的。LRSC 菌株的生物膜形成能力强于 LSSC 菌株,这可能与 bap 的黏附相关基因有关。此外,利奈唑胺耐药和利奈唑胺敏感的表皮葡萄球菌可以通过质谱特征快速鉴定。据我们所知,本研究首次报道了 LRSC 的生物膜形成能力,以及 MALDI-TOF MS 用于区分 LRSC 和 LSSC 的潜在用途。